English
SpanishTrusted Resources: Education
Scientific literature and patient education texts
Severity of SMA Muscle Impairment Prior to Treatment May Have Implications for Nusinersen Efficacy
source: The American Journal of Managed Care - AJMC
year: 2022
authors: Jaime Rosenberg
summary/abstract:A new study has found that the severity of muscle impairment and scoliosis before treatment may help predict response to nusinersen for certain patients with spinal muscular atrophy (SMA).
The retrospective study of patients with SMA type 2 and 3, published in Brain and Development, found that the severity of fatty infiltration and muscle atrophy at the start of treatment had implications for changes in motor function after treatment with nusinersen. The findings, which the researchers say highlight the importance of early diagnosis and initiation of treatment, come amid efforts to determine efficacy trends among the several treatment options for the condition.
read more
BookmarkRelated Content
-
Organotypic Spinal Cord Cultures: An in Vitro 3D Model to Preliminary Screen Treatments for Spinal Muscular AtrophySpinal muscular atrophy (SMA) is a sever...
-
Guidance on Gene Replacement Therapy in Spinal Muscular Atrophy: A Canadian PerspectiveSpinal muscular atrophy (SMA) is the sec...
-
5q Spinal Muscular Atrophy (SMA) Webinarhttps://www.youtube.com/watch?v=X9YpaTJO...
-
Scholar Rock Provides Corporate Update and Highlights Priorities for 2022Scholar Rock, a clinical-stage biopharma...
-
Intrathecal Administration of Nusinersen Using the Ommaya Reservoir in an Adult With 5q-Related Spinal Muscular Atro...Spinal muscular atrophy (SMA) is a hered...
-
Stanford Healthcare – Spinal Muscular AtrophyStanford Neuromuscular Program has exten...
-
Claudia A. Chiriboga, MDClaudia A. Chiriboga, MD is Professor of...
Powered by
In partnership with
